In the Nature’s Sunshine Q1 Products (Nasdaq: NATR), a trusted leader in the natural health and wellness sector, has reported robust financial results for the first quarter of 2025. The company achieved net sales of $113.2 million, marking a 2% year-over-year increase, and a 5% rise in constant currency terms.
CEO Terrence Moorehead highlighted the company’s strong momentum, especially in Asia and Europe, where countries like Taiwan, Japan, and Central Europe delivered double-digit growth.
“Despite economic headwinds, we’re seeing healthy signs of stability and growth,” Moorehead stated. “We’re also seeing early signs of improvement in North America and better gross margin results.”
Net Sales: $113.2 million (↑ 2%)
GAAP Net Income: $4.7 million, up 104% YoY
Earnings per Share: $0.25 (vs. $0.12 in Q1 2024)
Adjusted EBITDA: $11.0 million (↑ 20%)
Gross Margin: 72.1% (vs. 71.2% in Q1 2024)
| Region | Q1 2025 Sales | Change (%) | Constant Currency Growth |
|---|---|---|---|
| Asia | $48.7M | +5.3% | +10.1% |
| Europe | $24.1M | +8.2% | +8.6% |
| North America | $35.0M | -4.1% | -3.7% |
| Latin America/Other | $5.5M | -8.2% | -3.7% |
Repurchased 38,000 shares for $0.5M
Authorized an additional $25M stock buyback
$86.5M in cash and zero debt
The Nature’s Sunshine, headquartered in Utah, operates in over 40 countries and manufactures its own products to ensure the highest standards. It remains committed to delivering premium herbal and nutritional supplements with unmatched quality and efficacy.
Click here to learn more
There are no reviews yet. Be the first one to write one.
